TY - JOUR
T1 - Brachiocephalic vein for percutaneous ultrasound-guided central line positioning in children
T2 - A 20-month preliminary experience with 109 procedures
AU - Avanzini, Stefano
AU - Mameli, Leila
AU - Disma, Nicola
AU - Zanaboni, Clelia
AU - Dato, Andrea
AU - Montobbio, Giovanni
AU - Montagnini, Luigi
AU - Bevilacqua, Michela
AU - Pierri, Filomena
AU - Conte, Massimo
AU - Amoroso, Loredana
AU - Pala, Giovanna
AU - Pestarino, Sara
AU - Castagnola, Elio
AU - Molinari, Angelo Claudio
AU - Micalizzi, Concetta
AU - Morreale, Giuseppe
AU - Mattioli, Girolamo
AU - Pini Prato, A.
PY - 2016
Y1 - 2016
N2 - Background: Ultrasound-guided (USG) cannulation of the brachiocephalic vein (BCV) is gaining worldwide consensus for central venous access in children. This study reports a 20-month experience with this approach in children. Methods: All patients who underwent percutaneous USG central venous catheter (CVC) positioning in the BCV between August 2013 and March 2015 have been included. Devices inserted during this period were open-ended, either single or double-lumen tunneled CVC. Our series was divided into three consecutive study periods in order to determine the relative incidence of repositioning and complications. Results: During the study period, a total of 95 patients underwent 109 CVC insertions in the BCV. The median length of CVC duration was 230 days for a total of 23,212 catheter days. No major intraoperative complications occurred. Overall rate of CVC-related postoperative complications requiring repositioning or precocious removal was 0.90 per 1,000 catheter days and involved 21 CVC (19%, 95% confidence interval 13-28). These included 18 dislodgments, two infections, and one malfunction. Double-lumen CVCs represented the only significant risk factor for complications (52% complications-three per 1,000 catheter days). Conclusion: USG supraclavicular cannulation of the BCV represents a safe approach for central line placement in children. It proved to be versatile, as it can be used in premature infants as well as in adolescents. Provided it is adopted by operators experienced in USG cannulation, we strongly suggest to resort to this approach as a first-line choice in children undergoing tunnelled central line placement for long-lasting therapy.
AB - Background: Ultrasound-guided (USG) cannulation of the brachiocephalic vein (BCV) is gaining worldwide consensus for central venous access in children. This study reports a 20-month experience with this approach in children. Methods: All patients who underwent percutaneous USG central venous catheter (CVC) positioning in the BCV between August 2013 and March 2015 have been included. Devices inserted during this period were open-ended, either single or double-lumen tunneled CVC. Our series was divided into three consecutive study periods in order to determine the relative incidence of repositioning and complications. Results: During the study period, a total of 95 patients underwent 109 CVC insertions in the BCV. The median length of CVC duration was 230 days for a total of 23,212 catheter days. No major intraoperative complications occurred. Overall rate of CVC-related postoperative complications requiring repositioning or precocious removal was 0.90 per 1,000 catheter days and involved 21 CVC (19%, 95% confidence interval 13-28). These included 18 dislodgments, two infections, and one malfunction. Double-lumen CVCs represented the only significant risk factor for complications (52% complications-three per 1,000 catheter days). Conclusion: USG supraclavicular cannulation of the BCV represents a safe approach for central line placement in children. It proved to be versatile, as it can be used in premature infants as well as in adolescents. Provided it is adopted by operators experienced in USG cannulation, we strongly suggest to resort to this approach as a first-line choice in children undergoing tunnelled central line placement for long-lasting therapy.
KW - Brachiocephalic vein
KW - Chemotherapy
KW - CVC
KW - Total parenteral nutrition
KW - Ultrasound
UR - http://www.scopus.com/inward/record.url?scp=84992390920&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84992390920&partnerID=8YFLogxK
U2 - 10.1002/pbc.26202
DO - 10.1002/pbc.26202
M3 - Article
AN - SCOPUS:84992390920
SN - 1545-5009
JO - Pediatric Blood and Cancer
JF - Pediatric Blood and Cancer
ER -